Jatenzo Cost in New York: Pricing, Insurance, and Savings in 2026

What Jatenzo Costs at New York Retail Pharmacies in 2026

The sticker price for Jatenzo at New York retail pharmacies averages $900 per month in 2026, matching Tolmar's manufacturer list price. This figure applies to patients paying entirely out of pocket without insurance or discount programs. Actual costs vary by pharmacy, location within the state, and whether any coupon or savings card is applied.

Jatenzo (oral testosterone undecanoate) received FDA approval in March 2019 as the first oral testosterone replacement therapy for adult men with hypogonadism caused by specific medical conditions. The approval was based on a 166-patient open-label trial by Swerdloff et al. (2020) showing that 87% of men achieved average testosterone concentrations within the normal range (300 to 1 to 100 ng/dL) at the end of the titration period [1]. The drug is taken as a soft gelatin capsule twice daily with food, which distinguishes it from injectable and topical testosterone formulations.

New York pharmacies in Manhattan, Brooklyn, and other boroughs may quote slightly different prices depending on their wholesale contracts. Large chains such as CVS and Walgreens tend to cluster around the $900 mark, while independent pharmacies occasionally offer modest price differences. Patients should always request the cash price upfront and compare across at least two or three pharmacies before filling.

New York Medicaid Coverage for Jatenzo

New York Medicaid covers Jatenzo with prior authorization. This means the prescribing clinician must submit clinical documentation confirming the diagnosis of hypogonadism due to a recognized medical condition before the state will approve reimbursement.

The prior authorization process typically requires evidence of two morning serum testosterone measurements below 300 ng/dL, consistent with Endocrine Society Clinical Practice Guidelines (2018) recommendations for diagnosing male hypogonadism [2]. The prescriber must also document the underlying etiology (e.g., Klinefelter syndrome, pituitary disease, chemotherapy-induced gonadal failure) rather than age-related decline alone.

New York's Medicaid Preferred Drug List updates quarterly. Patients or prescribers who receive an initial denial can file a formulary exception request. The turnaround for standard PA review is typically 24 to 72 hours, with urgent requests processed within 24 hours under New York State Department of Health guidelines. Medicaid managed care organizations such as Healthfirst, Fidelis Care, and Molina Healthcare of New York each maintain their own formulary tiers, so the copay amount after PA approval will depend on the specific plan.

For Medicaid-enrolled patients in New York City, Federally Qualified Health Centers (FQHCs) such as NYC Health + Hospitals facilities can assist with PA submission and may have social workers who help coordinate the paperwork. This support often shortens the time from prescription to dispensing.

Commercial Insurance Coverage in New York

Most major commercial insurers operating in New York cover Jatenzo, though placement on formulary tiers varies. Plans from UnitedHealthcare, Aetna, Cigna, Empire BlueCross BlueShield, and Oscar Health generally list Jatenzo on specialty or non-preferred brand tiers, which means higher copays compared to generic medications.

Prior authorization requirements are nearly universal among commercial plans. The documentation mirrors what Medicaid requires: two confirmed low morning testosterone levels plus a qualifying diagnosis. Some plans also impose step therapy, requiring that the patient try and fail a generic injectable testosterone (such as testosterone cypionate) or a topical gel before covering oral testosterone undecanoate. Step therapy adds weeks to the process but can be appealed if a clinician documents why injectables or topicals are medically inappropriate for the patient.

Copays for Jatenzo on commercial plans in New York typically fall between $50 and $150 per month after PA approval, depending on the plan's cost-sharing structure. High-deductible health plans may require the patient to pay the full $900 until the deductible is met. Patients enrolled in New York State of Health (the state's ACA marketplace) plans should check their specific formulary, since Essential Health Benefit rules require coverage of at least one drug in each therapeutic class but do not mandate coverage of every brand.

A 2024 survey of testosterone prescribing patterns found that insurance-related barriers remain the most common reason patients discontinue branded oral testosterone in favor of injectable alternatives [3]. In New York, where the cost of living is already high, affordability directly influences adherence. Clinicians should proactively discuss copay assistance at the time of prescribing.

How the Tolmar Savings Card Works in New York

Tolmar Pharmaceuticals offers a manufacturer savings card for Jatenzo that can reduce the out-of-pocket cost to $0 per month for eligible patients. The card is available to commercially insured patients and cannot be combined with government insurance programs including Medicaid, Medicare, Tricare, or VA benefits.

Eligibility requirements are straightforward. The patient must have commercial or employer-sponsored insurance that covers Jatenzo, even if the copay is high. The savings card covers the difference between the plan's copay and $0, up to a maximum annual benefit (typically $13,000 per year, though Tolmar may adjust this cap). Patients can enroll online through Tolmar's Jatenzo website or by calling the number on the product's prescribing information.

New York pharmacies process the savings card as a secondary insurance claim. The pharmacist runs the primary commercial insurance first, then applies the savings card to cover the remaining copay. One common issue: if a pharmacy's system does not recognize the BIN and PCN numbers on the card, the transaction may reject. Patients should ask the pharmacist to manually enter the card details rather than scanning.

The savings card renews annually and requires re-enrollment each calendar year. Patients who lose commercial coverage mid-year become ineligible. There is no income restriction for commercial patients. Uninsured patients in New York can contact Tolmar's patient assistance program directly, though availability and terms for uninsured patients differ from the savings card program.

Compounded Oral Testosterone Undecanoate in New York

Compounded oral testosterone undecanoate is available in New York through licensed 503A compounding pharmacies. New York's Board of Pharmacy maintains strict oversight over compounding operations, and pharmacies must hold appropriate state licenses and comply with USP <795> and USP <797> standards for non-sterile and sterile compounding, respectively.

The cost of compounded oral testosterone undecanoate from 503A pharmacies in New York can be dramatically lower than branded Jatenzo. Some pharmacies offer 30-day supplies for under $100, with prices varying based on the dose, capsule count, and pharmacy markup. A few New York compounders have quoted prices as low as $40 to $80 per month for standard doses, though these figures fluctuate.

There are important differences between compounded and branded products. Jatenzo uses a proprietary self-emulsifying drug delivery system (SEDDS) designed to enhance absorption through the lymphatic system, bypassing first-pass hepatic metabolism. This technology was validated in the Swerdloff et al. registration trial and is specific to the branded formulation [1]. Compounded versions may use different excipients and delivery mechanisms, and they do not undergo FDA review for bioequivalence.

The FDA's position on compounding permits 503A pharmacies to prepare compounded medications based on individual patient prescriptions when a prescriber determines the commercially available product is not appropriate [4]. Reasons might include allergy to an inactive ingredient in Jatenzo or a need for a dose not commercially available.

Patients considering compounded oral testosterone undecanoate in New York should verify that their pharmacy holds a valid New York State license, ask for third-party potency testing results, and discuss bioavailability differences with their prescriber. The American Urological Association does not specifically endorse or discourage compounded testosterone but emphasizes the importance of monitoring serum levels regardless of the formulation source, per AUA/Endocrine Society guidance [2].

Telehealth Prescribing of Jatenzo in New York

Telehealth prescribing of Jatenzo is legal in New York. Clinicians licensed in the state can evaluate, diagnose, and prescribe testosterone replacement therapy via video or audio-only visits, following the same clinical standards that apply to in-person encounters.

New York expanded its telehealth regulations during the COVID-19 pandemic and has since made many of those flexibilities permanent through legislation signed in 2023. A prescriber must still confirm the diagnosis with laboratory work. Blood draws for total testosterone, free testosterone, LH, and FSH can be ordered remotely and completed at any Quest Diagnostics, Labcorp, or hospital lab location across the state.

Several telehealth platforms operating in New York offer testosterone replacement therapy, including Jatenzo specifically. Patients should confirm that the platform's clinicians hold active New York medical licenses and that the platform can transmit prescriptions to New York pharmacies. The prescription must be sent electronically (e-prescribing), as New York mandates electronic prescribing for controlled and non-controlled substances under the I-STOP law. Testosterone undecanoate is classified as a Schedule III controlled substance under both federal and New York State law [5].

Telehealth consultations range from $99 to $250 for an initial visit in New York, depending on the platform. Follow-up visits are typically $75 to $150. Some platforms bundle lab work into their pricing. Insurance may reimburse telehealth visits at the same rate as in-person visits under New York's telehealth parity law, though patient responsibility for copays and coinsurance still applies.

Comparing Jatenzo to Other Testosterone Options in New York

Jatenzo is the only FDA-approved oral testosterone undecanoate capsule on the U.S. market, but it competes with several other testosterone replacement formulations available in New York. Understanding the price differences helps patients and prescribers select the most practical option.

Generic testosterone cypionate injections remain the least expensive TRT option, with cash prices as low as $30 to $60 for a 10 mL multi-dose vial (200 mg/mL) at New York pharmacies. This supply can last 8 to 10 weeks depending on the prescribed dose. Testosterone gel (generic AndroGel 1.62%) costs approximately $80 to $200 per month at cash price. Natesto (testosterone nasal gel) carries a list price of roughly $600 per month [6].

The convenience of twice-daily oral dosing is Jatenzo's primary differentiator. In the Swerdloff et al. trial, the most common adverse reactions were increases in hematocrit (24.2%), headache (5.5%), and nausea (4.8%) [1]. Blood pressure increases were observed in a subset of patients, prompting the FDA to include a boxed warning about the potential for major adverse cardiovascular events in patients with known cardiovascular risk factors. The Endocrine Society guidelines recommend monitoring hematocrit, PSA, and cardiovascular risk markers at 3, 6, and 12 months after starting any testosterone formulation, then annually [2].

For patients in New York who prefer not to self-inject and want to avoid topical transfer risk (a real concern for men living with partners or children), Jatenzo fills a specific clinical niche. The $900 monthly price tag is the barrier. With the Tolmar savings card reducing commercially insured copays to $0, the effective cost for many patients drops substantially.

Tips for Reducing Jatenzo Costs in New York

Several strategies can lower what New York patients actually pay for Jatenzo.

Use the Tolmar savings card first. Eligible commercially insured patients can bring their copay to $0. Enrollment takes minutes.

Ask about formulary exceptions. If a plan does not cover Jatenzo or requires step therapy, the prescriber can submit a formulary exception letter explaining medical necessity. Documented skin reactions to topical testosterone or needle phobia that prevents injectable use are common grounds for exception.

Compare pharmacy prices. GoodRx and RxSaver show real-time Jatenzo pricing across New York pharmacies. Prices can vary by $50 to $100 depending on the pharmacy.

Consider mail-order pharmacy. Some New York insurance plans offer lower copays for 90-day mail-order prescriptions compared to 30-day retail fills. Check with the plan's pharmacy benefit manager.

Explore patient assistance. Uninsured or underinsured patients should contact Tolmar's patient services team directly. Manufacturer patient assistance programs (PAPs) for branded drugs often provide the medication free of charge to qualifying low-income patients, with household income thresholds typically set at 300% to 400% of the federal poverty level.

Evaluate compounded alternatives with your prescriber. If the branded product's cost is prohibitive even after all discounts, a compounded oral testosterone undecanoate from a licensed New York 503A pharmacy may cost $40 to $80 per month. The prescriber should monitor serum testosterone levels closely when switching formulations to confirm adequate absorption.